BackOrient Pharma , Ltd. Overview

Orient Pharma , Ltd. Current Cash

Latest current cash for 4166.TWO: $630M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$633.56M
↑ 18.35% YoYΔ $98.22M vs prior year quarter

Peer trimmed avg / median

Loading

Orient Pharma , Ltd. Current Cash History

Loading

Orient Pharma , Ltd. vs. peers: Current Cash Comparison

Loading

Orient Pharma , Ltd. Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Orient Pharma , Ltd. (4166.TWO) FAQ

As of the most recent data (September 2026), 4166.TWO shows a current cash of $630M. That compares with $540M in the prior-year period — up 18.3% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 4166.TWO's current cash is now $630M (was $540M) — a 18.3% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Orient Pharma , Ltd. is outperforming or lagging.

Tracking 4166.TWO's current cash over time shows whether Orient Pharma , Ltd. is scaling, shrinking, or reshaping that part of the business. The current reading is $630M That compares with $540M in the prior-year period — up 18.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has Orient Pharma , Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $630M) with ownership activity and broader fundamentals.

Questions & Answers